Keyword: Olivier Brandicourt

News

Medivation not Bending to Sanofi Pressure

09.05.2016 - Sanofi is turning up the heat on its acquisition target, US biopharmaceuticals producer Medivation, but the strategy doesn’t seem to be working. Last week, the French drugmaker...

News

Sanofi Seals two Oncology Partnerships

14.01.2016 - French drugmaker Sanofi has simultaneously announced collaborations with two biotechnology firms, together worth up to €1.2 billion. The first link-up, worth $750 million (€690...

News

Sanofi and Boehringer Ingelheim Agree Asset Swap

16.12.2015 - French drugmaker Sanofi and German pharmaceutical company Boehringer Ingelheim have begun exclusive negotiations toward a swap of Sanofi’s subsidiary Merial, a manufacturer of...

Markets & Companies

Pharma Players Mostly Lift 2015 Guidance

07.10.2015 - After a challenging second quarter and first half 2015 – once again marked by foreign exchange turbulence and the impact of acquisitions and divestments – the international...

News

Sanofi Teams with Google on Diabetes Care

01.09.2015 - French pharmaceutical producer Sanofi has announced plans to cooperate with the life sciences team at Google to improve care and outcomes for people with type 1 and type 2 diabetes...

News

Sanofi to Streamline Global Organization From 2016

16.07.2015 - French drugmaker Sanofi has announced plans to streamline its corporate structure with effect from January 2016. The company pointed to its heritage formed from a combination of...

News

New Sanofi Chief’s “Welcome Bonus” Slammed

03.03.2015 - French pharmaceuticals producer group Sanofi has come under fire from French government ministers over a welcome bonus planned for its new CEO. Olivier Brandicourt, who moves to...

News

Richard Pott Picked to Chair Bayer MaterialScience Supervisory Board

26.02.2015 - Richard Pott, until 2013 Bayer group managing board with responsibility for Strategy and Human Resources along with the regions Americas, Africa and Middle East, has been approved...